Publications

Journal Article Ppublish 430 citations
Electronic publication date
July 23, 2011

View on Pubmed.gov 21779440 | View on doi.org 10.1177/1947601...

PTEN Tumor Suppressor Network in PI3K-Akt Pathway Control.

Search for publications in this journal Genes Cancer - 1(12):1170-7

Abstract

The PI3K-Akt pathway is a major survival pathway activated in cancer. Efforts to develop targeted therapies have not been fully successful, mainly because of extensive internal intrapathway or external interpathway negative feedback loops or because of networking between pathway suppressors. The PTEN tumor suppressor is the major brake of the pathway and a common target for inactivation in somatic cancers. This review will highlight the networking of PTEN with other inhibitors of the pathway, relevant to cancer progression. PTEN constitutes the main node of the inhibitory network, and a series of convergences at different levels in the PI3K-Akt pathway, starting from those with growth factor receptors, will be described. As PTEN exerts enzymatic activity as a phosphatidylinositol-3,4,5-trisphosphate (PIP(3)) phosphatase, thus opposing the activity of PI3K, the concerted actions to increase the availability of PIP(3) in cancer cells, relying either on other phosphoinositide enzymes or on the intrinsic regulation of PTEN activity by other molecules, will be discussed. In particular, the synergy between PTEN and the circle of its direct interacting proteins will be brought forth in an attempt to understand both the activation of the PI3K-Akt pathway and the connections with other parallel oncogenic pathways. The understanding of the interplay between the modulators of the PI3K-Akt pathway in cancer should eventually lead to the design of therapeutic approaches with increased efficacy in the clinic.

References

Oncogene. 2007 Aug 9;26(36):5290-9

Annu Rev Biochem. 2001;70:247-79

Cell. 2011 Jan 21;144(2):187-99

Curr Biol. 2000 Oct 5;10(19):1201-4

Cited by 430 citations (total)

Journal Article Review

Ubiquitylation in immune disorders and cancer: from molecular mechanisms to therapeutic implications.

Electronic publication date October 25, 2012

Search for publications in this journal EMBO Mol Med

Simone Fulda [...] Ivan Dikic et al.

Conjugation of ubiquitin to proteins (ubiquitylation) has emerged to be one of the most crucial post-translational modifications controlling virtually all...

Journal Article

Identification and evaluation of plasma microRNAs for early detection of colorectal cancer.

Electronic publication date January 1, 2014

Search for publications in this journal PLoS One

Xiaoya Luo [...] Hermann Brenner et al.

BACKGROUND

Colorectal cancer (CRC) is one of the most commonly diagnosed cancers. Circulating microRNAs (miRNAs) have been suggested as potentially promising...

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Specialties